Allergan to Host First Quarter 2016 Earnings Conference Call and Webcast

DUBLIN, April 20, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it intends to release first quarter 2016 financial results on Tuesday, May 10, 2016, prior to the open of the U.S. financial markets. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, May 10, 2016 to discuss its financial results. The dial-in number to access the call is U.S./Canada [phone], International [phone], and the conference ID is 94452083.

Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 11:30 PM Eastern Time on May 24, 2016. The replay may be accessed by dialing [phone] and entering conference ID 94452083.  From international locations, the replay may be accessed by dialing [phone] and entering the same conference ID. To access the webcast, go to Allergan's Investor Relations Web site at http://ir.allergan.com. A replay of the webcast will also be available.

About Allergan

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma.  Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals and biologic products for patients around the world.

Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry and a leading position in the submission of generic product applications globally.

With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.

For more information, visit Allergan's website at www.allergan.com.

Forward-Looking Statement

Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Allergan's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Allergan disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Allergan's current expectations depending upon a number of factors affecting Allergan's business. These factors include, among others, the difficulty of predicting the timing or outcome of FDA approvals or actions, if any; the impact of competitive products and pricing; market acceptance of and continued demand for Allergan's products; difficulties or delays in manufacturing; and other risks and uncertainties detailed in Allergan's periodic public filings with the Securities and Exchange Commission, including but not limited to Allergan's Annual Report on Form 10-K for the year ended December 31, 2015 (certain of such periodic public filings having been filed under the "Actavis plc" name). Except as expressly required by law, Allergan disclaims any intent or obligation to update these forward-looking statements.

CONTACTS:
	Investors:
	Lisa DeFrancesco
	[phone]
	Media:
	Mark Marmur
	[phone]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/allergan-to-host-first-quarter-2016-earnings-conference-call-and-webcast-300254260.html

SOURCE Allergan plc

Copyright 2016 PR Newswire